InicioACTG • NASDAQ
add
Acacia Research Corp
Cierre anterior
5,30 $
Intervalo diario
5,25 $ - 5,40 $
Intervalo anual
3,43 $ - 5,47 $
Cap. bursátil
540,12 M USD
Volumen medio
210,23 mil
Relación precio-beneficio
141,56
Rentabilidad por dividendo
-
Bolsa de valores principal
NASDAQ
Noticias sobre los mercados
Datos financieros
Estado de resultados
Ingresos
Ingresos netos
(USD) | mar 2024info | Cambio interanual |
---|---|---|
Ingresos | 24,32 M | 64,29 % |
Gastos operativos | 14,04 M | -0,90 % |
Ingresos netos | -186,00 mil | -101,97 % |
Margen de beneficio neto | -0,76 | -101,19 % |
Beneficios por acción | 0,00 | -95,12 % |
EBITDA | 2,48 M | 141,75 % |
Tipo impositivo efectivo | 85,44 % | — |
Balance general
Activos totales
Responsabilidades totales
(USD) | mar 2024info | Cambio interanual |
---|---|---|
Efectivo y a corto plazo | 498,43 M | 7,96 % |
Activos totales | 631,72 M | 13,50 % |
Responsabilidades totales | 42,12 M | -74,87 % |
Patrimonio total | 589,60 M | — |
Acciones en circulación | 100,02 M | — |
Precio-valor contable | 0,93 | — |
Rentabilidad económica | -0,82 % | — |
Retorno sobre capital | -0,86 % | — |
Flujo de caja
Variación neta del flujo de caja
(USD) | mar 2024info | Cambio interanual |
---|---|---|
Ingresos netos | -186,00 mil | -101,97 % |
Efectivo de operaciones | 54,84 M | 1.360,96 % |
Efectivo de inversión | 42,04 M | 1.410,60 % |
Efectivo de financiación | 1,83 M | -97,66 % |
Variación neta del flujo de caja | 98,67 M | 29,08 % |
Flujo de caja libre | 62,10 M | 3.065,69 % |
Información sobre la empresa
Acacia Research Corporation is a publicly traded American company based in New York City. Acacia partners with patent owners such as inventors and universities to license patents that are infringed. Roughly 95% of the company's business involves licensing infringed patents on behalf of patent owners to corporations through patent litigation.
Acacia was incorporated in California in 1993 and is based in New York City. The company was consisted of two divisions: Acacia Technologies and CombiMatrix Group. The former covers the development, acquisition, licensing and enforcement of patented technologies. It creates a subsidiary company that acts as a special purpose entity for each set of patents that it enforces. The patent owner assigns the infringed patents to the subsidiary and the subsidiary then licenses the patents to companies who are infringing. Acacia and the patent owner split any revenues generated from licensing the patents on a 50/50 basis. Acacia's second division, CombiMatrix, constituted its life sciences business. This division, which Acacia held from 2002 until 2007, operated as a subsidiary. Invitae acquired CombiMatrix in 2017. Wikipedia
Fundación
1993
Sitio web
Empleados
102